1887

Journal of Medical Microbiology logo

Volume 47, Issue 12

Different O and K Serotype Distributions among Clinical and Environmental Strains of Free

Abstract

Summary

Recent revision of the O serotyping scheme for has allowed the definitive serological identification of a collection of 511 epidemiologically distinct strains in terms of both lipopolysaccharide (O) antigens and capsular (K) antigens. High levels of typability were achieved, 88% and 91% respectively, with only 2% failing to type with either method. in most cases, non-typability was due to a lack of antigen, i.e., the strains produced only rough LPS or were acapsular, suggesting that typability would be little improved by the discovery of additional serotypes. the distribution of the 58 O:K serotypes was very uneven, with O14:K14 accounting for 30% of the 423 clinical strains in the collection, but only 5% of the 88 non-clinical, environmental strains. Thus, the prevalence of O14:K14 strains in hospitals is not reflected in the environment. Similar conclusions were valid for O27:K14, O21:K3 and O21:K14 strains, as well as those with rough lipopolysaccharide. Conversely, the proportions of O6:K3, O6:K14, O8:K14 or O28:K28 strains were significantly lower among the clinical collection than among their environmental counterparts (12% in total rather than 65%). This suggests that O14:K14 may have a selective advantage in colonising or infecting hospitalised patients and, therefore, that the O14 and K14 polysaccharides themselves may contribute towards the apparent pathogenicity of these serotypes.

  • Received:
  • Accepted:
  • Published Online:
© 1998 The Pathological Society of Great Britain and Ireland
Loading

Article metrics loading...

/content/journal/jmm/10.1099/00222615-47-12-1097
1998-12-01
2024-04-20
Loading full text...

Full text loading...

/deliver/fulltext/jmm/47/12/medmicro-47-12-1097.html?itemId=/content/journal/jmm/10.1099/00222615-47-12-1097&mimeType=html&fmt=ahah

References

  1. Grimont P. A. D., Grimont F., Starr M. P. Serratia species isolated from plants. Curr Microbiol 1981; 5:317–322
     [Google Scholar]
  2. Grimont P. A. D., Grimont F. The genus Serratia. In Starr M. P., Stolp H., Truper H. G., Balows A., Schlegel F. I. G. (eds) The prokaryotes: a handbook on habitats, isolation and identification of bacteria vol 2 Berlin: Springer-Verlag; 19811187–1203
     [Google Scholar]
  3. Grimont P. A. D., Grimont F. The genus Serratia. Annu Rev Microbiol 1978; 32:221–248
     [Google Scholar]
  4. Grimont P. A. D., Grimont F., Lysenko O. Species and biotype identification of Serratia strains associated with insects. Curr Microbiol 1979; 2:139–142
     [Google Scholar]
  5. Pitt T. L., Erdman Y. J. Serological typing of Serratia marcescens. Methods Microbiol 1984; 15:173–211
     [Google Scholar]
  6. Pitt T. L., Erdman Y. J., Bucher C. The epidemiological type identification of Serratia marcescens from outbreaks of infection in hospitals. J Hyg 1980; 84:269–283
     [Google Scholar]
  7. Aucken H. M., Wilkinson S. G., Pitt T. L. Identification of capsular antigens in Serratia marcescens. J Clin Microbiol 1997; 35:59–63
     [Google Scholar]
  8. Aucken H. M., Wilkinson S. G., Pitt T. L. Re-evaluation the serotypes of Serratia marcescens and separation into two schemes based on lipopolysaccharide (O) and capsular polysaccharide (K) antigens. Microbiology 1998; 144:639–653
     [Google Scholar]
  9. King E. O., Ward M. K., Raney D. E. Two simple media for the demonstration of pyocyanin and fluorescin. J Lab Clin Med 1954; 44:301–307
     [Google Scholar]
  10. Farmer J. J., Davis B. R., Hickman-Brenner F. W. Biochemical identification of new species and biogroups of Enterobacteriaceae isolated from clinical specimens. J Clin Microbiol 1985; 21:46–76
     [Google Scholar]
  11. Holmes B., Dawson C. A., Pinning C. A. A revised probability matrix for the identification of Gram-negative, aerobic, rod-shaped, fermentative bacteria. J Gen Microbiol 1986; 132:3113–3135
     [Google Scholar]
  12. Aucken H. M., Pitt T. L. Lipopolysaccharide profile typing as a technique for the comparative typing of Gram-negative bacteria. J Clin Microbiol 1993; 31:1286–1289
     [Google Scholar]
  13. Davis B. R., Woodward J. M. Some relationships of the somatic antigens of a group of Serratia marcescens cultures. Can J Microbiol 1957; 3:591–597
     [Google Scholar]
  14. Ewing W. H., Davis B. R., Reavis R. W. Studies on the Serratia group. Atlanta: CDC Publications; 1959
     [Google Scholar]
  15. Ewing W. H., Johnson J. G., Davis B. R. The occurrence of Serratia marcescens in nosocomial infections. Atlanta: CDC Publications; 1962
     [Google Scholar]
  16. Sedlãk J., Dlabac V., Motlikovã M. The taxonomy of the Serratia genus. J Hyg Epidem 1965; 9:45–53
     [Google Scholar]
  17. Wilfert J. N., Barrett F. F., Ewing W. H., Finland M., Kass E. H. Serratia marcescens: biochemical, serological and epidemiological characteristics and antibiotic susceptibility of strains isolated at Boston City Hospital. Appl Microbiol 1970; 19:345–352
     [Google Scholar]
  18. Rubin S. J., Brock S., Chamberland M., Lyons R. W. Combined serotyping and biotyping of Serratia marcescens. J Clin Microbiol 1976; 3:582–585
     [Google Scholar]
  19. Anderhub B., Pitt T. L., Erdman Y. J., Willcox W. R. A comparison of typing methods for Serratia marcescens. J Hyg 1977; 79:89–102
     [Google Scholar]
  20. Le Minor S., Pigache F. [Antigenic study of “Serratia marcescens” isolated in France. II. Characterisation of O antigens and description of 5 new O factors, occurrence of serotypes and labelling of new H factors.] Ètude antigénique de souches de Serratia marcescens isolées en France. II. Caractérisation des antigènes O et individualisation de 5 nouveaux facteurs, frequence de serotypes et designation des nouveaux facteurs H. Ann Microbiol 1978; 129B:407–423
     [Google Scholar]
  21. Young V. M., Moody M. R., Morris M. J. Distribution of Serratia marcescens serotypes in cancer patients. J Med Microbiol 1980; 13:333–339
     [Google Scholar]
  22. Gaston M. A., Pitt T. L. Improved O-serotyping method for Serratia marcescens. J Clin Microbiol 1989; 27:2702–2705
     [Google Scholar]
  23. Gaston M. A., Duff P. S., Pitt T. L. Lipopolysaccharide heterogeneity in strains of Serratia marcescens agglutinated by O14 antiserum. Curr Microbiol 1988; 17:27–31
     [Google Scholar]
  24. Bale M., Sanford M., Hollis R., Pfaller M. A. Application of a biotyping system and DNA restriction fragment analysis to the study of Serratia marcescens from hospitalized patients. Diagn Microbiol Infect Dis 1993; 16:1–7
     [Google Scholar]
  25. Alonso R., Aucken H. M., Perez-Diaz J. C., Cookson B. D., Baquero F., Pitt T. L. Comparison of serotype, biotype and bacteriocin type with rDNA RFLP patterns for the type identification of Serratia marcescens. Epidemiol Infect 1993; 111:99–107
     [Google Scholar]
  26. Traub W. H., Eiden A., Leonhard B., Bauer D. Typing of nosocomial strains of Serratia marcescens: comparison of restriction enzyme cleaved genomic DNA fragment (PFGE) analysis with bacteriocin typing, biochemical profiles and serotyping. Zentralbl Bakteriol 1996; 284:93–106
     [Google Scholar]
  27. Debast S. B., Melchers W. J. G., Voss A., Hoogkamp-Korstanje J. A. A., Meis J. F. G. M. Epidemiological survey of an outbreak of multiresistant Serratia marcescens by PCR-fingerprinting. Infection 1995; 23:267–271
     [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jmm/10.1099/00222615-47-12-1097
Loading
Different O and K Serotype Distributions among Clinical and Environmental Strains of Serratia Marcescens
J. Med. Microbiol. 47, 1097 (1998); https://doi.org/10.1099/00222615-47-12-1097
/content/journal/jmm/10.1099/00222615-47-12-1097
/content/journal/jmm/10.1099/00222615-47-12-1097
Loading

Data & Media loading...

Most cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error